XML 26 R16.htm IDEA: XBRL DOCUMENT
v3.21.2

Net Income Per Common Share | 9 Months Ended
--- | ---
Sep. 30, 2021
Earnings Per Share [Abstract] |
Net Income Per Common Share | NET INCOME PER COMMON SHARE Basic net income per common share is computed by dividing net income by the weighted average number of common shares outstanding during each period. Diluted net income per common share assumes the exercise of outstanding SSARs and the vesting of performance share awards and RSUs using the treasury stock method when the effects of such assumptions are dilutive. A reconciliation of net income attributable to AGCO Corporation and subsidiaries and weighted average common shares outstanding for purposes of calculating basic and diluted net income per share for the three and nine months ended September 30, 2021 and 2020 is as follows (in millions, except per share data):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Basic net income per share: |  |  |  |  |  |  |
Net income attributable to AGCO Corporation and subsidiaries | $ | 181.3 |  |  | $ | 157.3 |  |  | $ | 614.9 |  |  | $ | 291.7 |
Weighted average number of common shares outstanding | 75.2 |  |  | 74.9 |  |  | 75.3 |  |  | 75.0 |
Basic net income per share attributable to AGCO Corporation and subsidiaries | $ | 2.41 |  |  | $ | 2.10 |  |  | $ | 8.16 |  |  | $ | 3.89 |
Diluted net income per share: |  |  |  |  |  |  |
Net income attributable to AGCO Corporation and subsidiaries | $ | 181.3 |  |  | $ | 157.3 |  |  | $ | 614.9 |  |  | $ | 291.7 |
Weighted average number of common shares outstanding | 75.2 |  |  | 74.9 |  |  | 75.3 |  |  | 75.0 |
Dilutive SSARs, performance share awards and RSUs | 0.4 |  |  | 0.5 |  |  | 0.5 |  |  | 0.5 |
Weighted average number of common shares and common share equivalents outstanding for purposes of computing diluted net income per share | 75.6 |  |  | 75.4 |  |  | 75.8 |  |  | 75.5 |
Diluted net income per share attributable to AGCO Corporation and subsidiaries | $ | 2.40 |  |  | $ | 2.09 |  |  | $ | 8.11 |  |  | $ | 3.86 |
There were no SSARs outstanding for the three and nine months ended September 30, 2021 that had an antidilutive impact. SSARs to purchase approximately 0.5 million and 0.7 million shares of the Company's common stock for the three and nine months ended September 30, 2020, respectively, were outstanding but not included in the calculation of weighted average common and common equivalent shares outstanding because they had an antidilutive impact.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration